Search Results

Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally recognized standards to ensures that our products and services meet the needs of our global clients through an effective quality management system.

Celprogen Inc. today announced that they have successfully finished printing 3D Brains from brain stem cells for studying neurological disease stages.